메뉴 건너뛰기




Volumn 20, Issue 8, 2014, Pages

Social impact of the burden of psoriasis: Effects on patients and practice

Author keywords

Burden; Healthcare reform; Patient; Physician; Psoriasis; Treatment

Indexed keywords

ADALIMUMAB; BRODALUMAB; ETANERCEPT; INFLIXIMAB; IXEKIZUMAB; SECUKINUMAB; USTEKINUMAB;

EID: 84906278947     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (50)

References (54)
  • 1
    • 84925862164 scopus 로고    scopus 로고
    • Cumulative life course impairment: Evidence for psoriasis
    • [PMID:23796812]
    • Mattei PL, Corey KC, Kimball AB. Cumulative life course impairment: evidence for psoriasis. Curr Probl Dermatol. 2013;44:82-90. [PMID:23796812]
    • (2013) Curr Probl Dermatol , vol.44 , pp. 82-90
    • Mattei, P.L.1    Corey, K.C.2    Kimball, A.B.3
  • 3
    • 84886876515 scopus 로고    scopus 로고
    • Quality-of-life effects of common dermatological diseases
    • [PMID:24049968]
    • Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg. 2013;32(2):101-9. [PMID:24049968]
    • (2013) Semin Cutan Med Surg , vol.32 , Issue.2 , pp. 101-109
    • Ahmed, A.1    Leon, A.2    Butler, D.C.3    Reichenberg, J.4
  • 5
    • 84880329838 scopus 로고    scopus 로고
    • A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
    • [PMID:23207011]
    • Bhutani T, Patel T, Koo B, Nguyen T, Hong J, Koo J. A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions. J Am Acad Dermatol. 2013;69(2):e79-88. [PMID:23207011]
    • (2013) J Am Acad Dermatol , vol.69 , Issue.2
    • Bhutani, T.1    Patel, T.2    Koo, B.3    Nguyen, T.4    Hong, J.5    Koo, J.6
  • 6
    • 20444502501 scopus 로고    scopus 로고
    • Involving the patient: Impact of inflammatory skin disease and patient-focused care
    • [PMID:15968267]
    • Feldman S, Behnam SM, Behnam SE, Koo JY. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol. 2005;53(1 Suppl 1)S78-85. [PMID:15968267]
    • (2005) J Am Acad Dermatol , vol.53 , Issue.1 SUPPL. 1
    • Feldman, S.1    Behnam, S.M.2    Behnam, S.E.3    Koo, J.Y.4
  • 8
    • 83655172559 scopus 로고    scopus 로고
    • A roadmap for improving healthcare service quality
    • [PMID:22201201]
    • Kennedy DM, Caselli RJ, Berry LL. A roadmap for improving healthcare service quality. J Healthc Manag. 2011;56(6):385-400. [PMID:22201201]
    • (2011) J Healthc Manag , vol.56 , Issue.6 , pp. 385-400
    • Kennedy, D.M.1    Caselli, R.J.2    Berry, L.L.3
  • 9
    • 21044440425 scopus 로고    scopus 로고
    • Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: A double-blind placebo-controlled trial
    • [PMID:15888152]
    • Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT, Guzzo C, Patel K, Menter A, Gottlieb AB. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Br J Dermatol. 2005;152(5):954-60. [PMID:15888152]
    • (2005) Br J Dermatol , vol.152 , Issue.5 , pp. 954-960
    • Feldman, S.R.1    Gordon, K.B.2    Bala, M.3    Evans, R.4    Li, S.5    Dooley, L.T.6    Guzzo, C.7    Patel, K.8    Menter, A.9    Gottlieb, A.B.10
  • 10
    • 79959816954 scopus 로고    scopus 로고
    • Impact of ustekinumab on healthrelated quality of life and sexual difficulties associated with psoriasis: Results from two phase III clinical trials
    • [PMID:21521375]
    • Guenther L, Han C, Szapary P, Schenkel B, Poulin Y, Bourcier M, Ortonne JP, Sofen HL. Impact of ustekinumab on healthrelated quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials. J Eur Acad Dermatol Venereol. 2011;25(7):851-7. [PMID:21521375]
    • (2011) J Eur Acad Dermatol Venereol , vol.25 , Issue.7 , pp. 851-857
    • Guenther, L.1    Han, C.2    Szapary, P.3    Schenkel, B.4    Poulin, Y.5    Bourcier, M.6    Ortonne, J.P.7    Sofen, H.L.8
  • 12
    • 0032085771 scopus 로고    scopus 로고
    • Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: An index of the stigma experience in dermatologic disorders
    • [PMID:9640555]
    • Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis. 1998;61(6):339-42. [PMID:9640555]
    • (1998) Cutis , vol.61 , Issue.6 , pp. 339-342
    • Gupta, M.A.1    Gupta, A.K.2    Watteel, G.N.3
  • 13
    • 18744406706 scopus 로고    scopus 로고
    • The psychological and social burdens of psoriasis
    • [PMID:15782923]
    • Young M. The psychological and social burdens of psoriasis. Dermatol Nurs. 2005;17(1):15-9. [PMID:15782923]
    • (2005) Dermatol Nurs , vol.17 , Issue.1 , pp. 15-19
    • Young, M.1
  • 14
    • 0027320785 scopus 로고
    • Psychosocial consequences of rejection and stigma feelings in psoriasis patients
    • [PMID:8407075]
    • Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993;32(8):587-91. [PMID:8407075]
    • (1993) Int J Dermatol , vol.32 , Issue.8 , pp. 587-591
    • Ginsburg, I.H.1    Link, B.G.2
  • 16
    • 77955134594 scopus 로고    scopus 로고
    • Sex and the skin: A qualitative study of patients with acne, psoriasis and atopic eczema
    • [PMID:20677083]
    • Magin P, Heading G, Adams J, Pond D. Sex and the skin: a qualitative study of patients with acne, psoriasis and atopic eczema. Psychol Health Med. 2010;15(4):454-62. [PMID:20677083]
    • (2010) Psychol Health Med , vol.15 , Issue.4 , pp. 454-462
    • Magin, P.1    Heading, G.2    Adams, J.3    Pond, D.4
  • 17
    • 84906254283 scopus 로고    scopus 로고
    • Impact of psoriasis on sexual activity
    • Available at, Accessed January 30, 2014
    • Splete H. Impact of psoriasis on sexual activity. Skin & Allergy News. 2013. Available at: http://www.skinandallergynews.com/index.php?id=159&tx_ttnews%5Btt_news%5D=223073&cHash=5d1771b5739545e6e7 17000274d012d0. Accessed January 30, 2014.
    • (2013) Skin & Allergy News
    • Splete, H.1
  • 18
    • 0028918535 scopus 로고
    • The effect of severe psoriasis on the quality of life of 369 patients
    • [PMID:7888360]
    • Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132(2):236-44. [PMID:7888360]
    • (1995) Br J Dermatol , vol.132 , Issue.2 , pp. 236-244
    • Finlay, A.Y.1    Coles, E.C.2
  • 19
    • 0035069606 scopus 로고    scopus 로고
    • The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey
    • [PMID:11255325]
    • Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280-4. [PMID:11255325]
    • (2001) Arch Dermatol , vol.137 , Issue.3 , pp. 280-284
    • Krueger, G.1    Koo, J.2    Lebwohl, M.3    Menter, A.4    Stern, R.S.5    Rolstad, T.6
  • 21
    • 33747081908 scopus 로고    scopus 로고
    • Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis
    • [PMID:16902286]
    • Schmitt JM, Ford DE. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology. 2006;213(2):102-10. [PMID:16902286]
    • (2006) Dermatology , vol.213 , Issue.2 , pp. 102-110
    • Schmitt, J.M.1    Ford, D.E.2
  • 22
    • 36049047981 scopus 로고    scopus 로고
    • Association of patient-reported psoriasis severity with income and employment
    • [PMID:17761358]
    • Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol. 2007;57(6):963-71. [PMID:17761358]
    • (2007) J Am Acad Dermatol , vol.57 , Issue.6 , pp. 963-971
    • Horn, E.J.1    Fox, K.M.2    Patel, V.3    Chiou, C.F.4    Dann, F.5    Lebwohl, M.6
  • 23
    • 40349095005 scopus 로고    scopus 로고
    • The psychosocial and occupational impact of chronic skin disease
    • [PMID:18318886]
    • Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54-9. [PMID:18318886]
    • (2008) Dermatol Ther , vol.21 , Issue.1 , pp. 54-59
    • Hong, J.1    Koo, B.2    Koo, J.3
  • 24
    • 84856245789 scopus 로고    scopus 로고
    • Quality-of-life instruments: Evaluation of the impact of psoriasis on patients
    • [PMID:22284142]
    • Heller MM, Wong JW, Nguyen TV, Lee ES, Bhutani T, Menter A, Koo JY. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatol Clin. 2012;30(2):281-91. [PMID:22284142]
    • (2012) Dermatol Clin , vol.30 , Issue.2 , pp. 281-291
    • Heller, M.M.1    Wong, J.W.2    Nguyen, T.V.3    Lee, E.S.4    Bhutani, T.5    Menter, A.6    Koo, J.Y.7
  • 25
    • 84900824464 scopus 로고    scopus 로고
    • The Psoriasis Symptom Diary: Development and content validity of a novel patient-reported outcome instrument
    • doi: 10.1111/j.365-4632.2012.05798.x. [Epub ahead of print]. [PMID:23557000]
    • Lebwohl M, Swensen AR, Nyirady J, Kim E, Gwaltney CJ, Strober BE. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument. Int J Dermatol. 2013 doi: 10.1111/j.365-4632.2012.05798.x. [Epub ahead of print]. [PMID:23557000]
    • (2013) Int J Dermatol
    • Lebwohl, M.1    Swensen, A.R.2    Nyirady, J.3    Kim, E.4    Gwaltney, C.J.5    Strober, B.E.6
  • 26
    • 20444466784 scopus 로고    scopus 로고
    • Decision points for the initiation of systemic treatment for psoriasis
    • [PMID:15965429]
    • Feldman SR, Koo JY, Menter A, Bagel J. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005;53(1):101-7. [PMID:15965429]
    • (2005) J Am Acad Dermatol , vol.53 , Issue.1 , pp. 101-107
    • Feldman, S.R.1    Koo, J.Y.2    Menter, A.3    Bagel, J.4
  • 27
    • 28844490562 scopus 로고    scopus 로고
    • Patient-reported outcomes of psoriasis improvement with etanercept therapy: Results of a randomized phase III trial
    • [PMID:16307657]
    • Krueger GG, Langley RG, Finlay AY, Griffiths CE, Woolley JM, Lalla D, Jahreis A. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol. 2005;153(6):1192-9. [PMID:16307657]
    • (2005) Br J Dermatol , vol.153 , Issue.6 , pp. 1192-1199
    • Krueger, G.G.1    Langley, R.G.2    Finlay, A.Y.3    Griffiths, C.E.4    Woolley, J.M.5    Lalla, D.6    Jahreis, A.7
  • 28
    • 33646547957 scopus 로고    scopus 로고
    • Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: A randomized controlled trial
    • [PMID:16704649]
    • Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. Br J Dermatol. 2006;154(6):1161-8. [PMID:16704649]
    • (2006) Br J Dermatol , vol.154 , Issue.6 , pp. 1161-1168
    • Reich, K.1    Nestle, F.O.2    Papp, K.3    Ortonne, J.P.4    Wu, Y.5    Bala, M.6    Evans, R.7    Guzzo, C.8    Li, S.9    Dooley, L.T.10    Griffiths, C.E.11
  • 29
    • 36849070806 scopus 로고    scopus 로고
    • Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
    • [PMID:18058494]
    • Revicki DA, Willian MK, Menter A, Gordon KB, Kimball AB, Leonardi CL, Langley RG, Kimel M, Okun M. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. J Dermatolog Treat. 2007;18(6):341-50. [PMID:18058494]
    • (2007) J Dermatolog Treat , vol.18 , Issue.6 , pp. 341-350
    • Revicki, D.A.1    Willian, M.K.2    Menter, A.3    Gordon, K.B.4    Kimball, A.B.5    Leonardi, C.L.6    Langley, R.G.7    Kimel, M.8    Okun, M.9
  • 30
    • 70350336843 scopus 로고    scopus 로고
    • Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis
    • [PMID:19752505]
    • Reich K, Segaert S, van de Kerkhof P, Durian C, Boussuge MP, Paolozzi L, Wajdula J, Boggs R. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. Dermatology. 2009;219(3):239-49. [PMID:19752505]
    • (2009) Dermatology , vol.219 , Issue.3 , pp. 239-249
    • Reich, K.1    Segaert, S.2    van de Kerkhof, P.3    Durian, C.4    Boussuge, M.P.5    Paolozzi, L.6    Wajdula, J.7    Boggs, R.8
  • 31
    • 84865634236 scopus 로고    scopus 로고
    • Japanese Ustekinumab Study G. Impact of ustekinumab on healthrelated quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial
    • [PMID:22409383]
    • Nakagawa H, Schenkel B, Kato M, Kato T, Igarashi A, Japanese Ustekinumab Study G. Impact of ustekinumab on healthrelated quality of life in Japanese patients with moderate-to-severe plaque psoriasis: results from a randomized, double-blind, placebo-controlled phase 2/3 trial. J Dermatol. 2012;39(9):761-9. [PMID:22409383]
    • (2012) J Dermatol , vol.39 , Issue.9 , pp. 761-769
    • Nakagawa, H.1    Schenkel, B.2    Kato, M.3    Kato, T.4    Igarashi, A.5
  • 32
    • 84879751896 scopus 로고    scopus 로고
    • Impact of TNF-α antagonists on the quality of life in selected skin diseases
    • [PMID:23670060]
    • Gisondi P, Girolomoni G. Impact of TNF-α antagonists on the quality of life in selected skin diseases. G Ital Dermatol Venereol. 2013;148(3):243-8. [PMID:23670060]
    • (2013) G Ital Dermatol Venereol , vol.148 , Issue.3 , pp. 243-248
    • Gisondi, P.1    Girolomoni, G.2
  • 33
    • 77955921585 scopus 로고    scopus 로고
    • Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
    • [PMID:20462664]
    • Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB, Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol. 2010;63(3):457-65. [PMID:20462664]
    • (2010) J Am Acad Dermatol , vol.63 , Issue.3 , pp. 457-465
    • Langley, R.G.1    Feldman, S.R.2    Han, C.3    Schenkel, B.4    Szapary, P.5    Hsu, M.C.6    Ortonne, J.P.7    Gordon, K.B.8    Kimball, A.B.9
  • 34
    • 80855163580 scopus 로고    scopus 로고
    • Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2
    • [PMID:21034290]
    • Reich K, Schenkel B, Zhao N, Szapary P, Augustin M, Bourcier M, Guenther L, Langley RG. Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2. J Dermatolog Treat. 2011;22(6):337-47. [PMID:21034290]
    • (2011) J Dermatolog Treat , vol.22 , Issue.6 , pp. 337-347
    • Reich, K.1    Schenkel, B.2    Zhao, N.3    Szapary, P.4    Augustin, M.5    Bourcier, M.6    Guenther, L.7    Langley, R.G.8
  • 35
    • 77950594947 scopus 로고    scopus 로고
    • The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
    • [PMID:20219265]
    • Menter A, Augustin M, Signorovitch J, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani P. The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol. 2010;62(5):812-18. [PMID:20219265]
    • (2010) J Am Acad Dermatol , vol.62 , Issue.5 , pp. 812-818
    • Menter, A.1    Augustin, M.2    Signorovitch, J.3    Yu, A.P.4    Wu, E.Q.5    Gupta, S.R.6    Bao, Y.7    Mulani, P.8
  • 36
    • 84855827132 scopus 로고    scopus 로고
    • The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
    • [PMID:21616560]
    • Kimball AB, Yu AP, Signorovitch J, Xie J, Tsaneva M, Gupta SR, Bao Y, Mulani PM. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol. 2012;66(2):e67-76. [PMID:21616560]
    • (2012) J Am Acad Dermatol , vol.66 , Issue.2
    • Kimball, A.B.1    Yu, A.P.2    Signorovitch, J.3    Xie, J.4    Tsaneva, M.5    Gupta, S.R.6    Bao, Y.7    Mulani, P.M.8
  • 39
    • 84896088319 scopus 로고    scopus 로고
    • Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: Use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory
    • [PMID:24079852]
    • Gordon KB, Kimball AB, Chau D, Viswanathan HN, Li J, Revicki DA, Kricorian G, Ortmeier BG. Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory. Br J Dermatol. 2014;170(3):705-15. [PMID:24079852]
    • (2014) Br J Dermatol , vol.170 , Issue.3 , pp. 705-715
    • Gordon, K.B.1    Kimball, A.B.2    Chau, D.3    Viswanathan, H.N.4    Li, J.5    Revicki, D.A.6    Kricorian, G.7    Ortmeier, B.G.8
  • 40
    • 84873124241 scopus 로고    scopus 로고
    • Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study
    • [PMID:23106107]
    • Papp KA, Langley RG, Sigurgeirsson B, Abe M, Baker DR, Konno P, Haemmerle S, Thurston HJ, Papavassilis C, Richards HB. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study. Br J Dermatol. 2013;168(2):412-21. [PMID:23106107]
    • (2013) Br J Dermatol , vol.168 , Issue.2 , pp. 412-421
    • Papp, K.A.1    Langley, R.G.2    Sigurgeirsson, B.3    Abe, M.4    Baker, D.R.5    Konno, P.6    Haemmerle, S.7    Thurston, H.J.8    Papavassilis, C.9    Richards, H.B.10
  • 42
    • 84885935651 scopus 로고    scopus 로고
    • Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the National Psoriasis Foundation surveys, 2003-2011
    • [PMID:23945732]
    • Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013;149(10):1180-5. [PMID:23945732]
    • (2013) JAMA Dermatol , vol.149 , Issue.10 , pp. 1180-1185
    • Armstrong, A.W.1    Robertson, A.D.2    Wu, J.3    Schupp, C.4    Lebwohl, M.G.5
  • 43
    • 84900471388 scopus 로고    scopus 로고
    • Identifying individual psychosocial and adherence support needs in patients with psoriasis: A multinational two-stage qualitative and quantitative study
    • [PMID:23663069]
    • Bewley A, Burrage DM, Ersser SJ, Hansen M, Ward C. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol. 2014;28(6):763-70. [PMID:23663069]
    • (2014) J Eur Acad Dermatol Venereol , vol.28 , Issue.6 , pp. 763-770
    • Bewley, A.1    Burrage, D.M.2    Ersser, S.J.3    Hansen, M.4    Ward, C.5
  • 44
    • 84881564770 scopus 로고    scopus 로고
    • Satisfaction with treatment among patients with psoriasis: A web-based survey study
    • [PMID:23565643]
    • van Cranenburgh OD, de Korte J, Sprangers MA, de Rie MA, Smets EM. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol. 2013;169(2):398-405. [PMID:23565643]
    • (2013) Br J Dermatol , vol.169 , Issue.2 , pp. 398-405
    • van Cranenburgh, O.D.1    de Korte, J.2    Sprangers, M.A.3    de Rie, M.A.4    Smets, E.M.5
  • 45
    • 46449094084 scopus 로고    scopus 로고
    • The impact of physical illness on sexual dysfunction
    • [PMID:18391558]
    • Clayton A, Ramamurthy S. The impact of physical illness on sexual dysfunction. Adv Psychosom Med. 2008;2970-88. [PMID:18391558]
    • (2008) Adv Psychosom Med , pp. 2970-2988
    • Clayton, A.1    Ramamurthy, S.2
  • 46
    • 77949506527 scopus 로고    scopus 로고
    • Provider-initiated pay-for-performance in a clinically integrated hospital network
    • [PMID:20151591]
    • Atkinson JG, Masiulis KE, Felgner L, Schumacher DN. Provider-initiated pay-for-performance in a clinically integrated hospital network. J Healthc Qual. 2010;32(1):42-50. [PMID:20151591]
    • (2010) J Healthc Qual , vol.32 , Issue.1 , pp. 42-50
    • Atkinson, J.G.1    Masiulis, K.E.2    Felgner, L.3    Schumacher, D.N.4
  • 47
    • 79955102875 scopus 로고    scopus 로고
    • Patient satisfaction in pay for performance programs
    • [PMID:21467898]
    • Press I, Fullam F. Patient satisfaction in pay for performance programs. Qual Manag Health Care. 2011;20(2):110-5. [PMID:21467898]
    • (2011) Qual Manag Health Care , vol.20 , Issue.2 , pp. 110-115
    • Press, I.1    Fullam, F.2
  • 48
    • 79952517218 scopus 로고    scopus 로고
    • Why measure patient satisfaction?
    • [PMID:21506460]
    • Riskind P, Fossey L, Brill K. Why measure patient satisfaction? J Med Pract Manage. 2011;26(4):217-20. [PMID:21506460]
    • (2011) J Med Pract Manage , vol.26 , Issue.4 , pp. 217-220
    • Riskind, P.1    Fossey, L.2    Brill, K.3
  • 49
    • 85028151954 scopus 로고    scopus 로고
    • Patient satisfaction Implications and predictors of success
    • [PMID:23677370]
    • Shirley ED, Sanders JO. Patient satisfaction: Implications and predictors of success. J Bone Joint Surg Am. 2013;95(10):e69. [PMID:23677370]
    • (2013) J Bone Joint Surg Am , vol.95 , Issue.10
    • Shirley, E.D.1    Sanders, J.O.2
  • 50
    • 84982887005 scopus 로고    scopus 로고
    • Agency For Healthcare Research and Quality Accessed March10, 2014Available at
    • CAHPS®: Consumer Assessment of Healthcare Providers and Systems. Agency for Healthcare Research and Quality. 2013. Available at: https://cahps.ahrq.gov/. Accessed March 10, 2014.
    • (2013) CAHPS®: Consumer Assessment of Healthcare Providers and Systems
  • 51
    • 84898734214 scopus 로고    scopus 로고
    • Centers For Medicare & Medicaid Services Available at, Accessed March 10, 2014
    • Medicare.gov. Hospital Compare. Centers for Medicare & Medicaid Services. Available at: www.medicare.gov/hospitalcompare. Accessed March 10, 2014.
    • Medicare.gov. Hospital Compare
  • 53
    • 84906271765 scopus 로고    scopus 로고
    • Physician quality measure reporting
    • Available at, Accessed March 10, 2014
    • Physician quality measure reporting. American Medical Associatio n. Available at: http://www.ama-assn.org/ama/pub/physician-resources/clinical-practice-improvement/clinical-quality/physician-quality-reporting-system.page. Accessed March 10, 2014.
    • American Medical Associatio N
  • 54
    • 84898734214 scopus 로고    scopus 로고
    • Centers For Medicare & Medicaid Services Available at, Accessed March 10, 2014
    • Medicare.gov. Physician Compare. Centers for Medicare & Medicaid Services. Available at: www.medicare.gov/physiciancompare. Accessed March 10, 2014.
    • Medicare.gov. Physician Compare


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.